<p>BALB/c mice were immunized twice (V1 and V2) with 10<sup>7</sup> pfu of D1701-V-HAh5n and depletion was performed during immunization <b>(A)</b>, during challenge <b>(B)</b> or during immunization and challenge <b>(C)</b>. Challenge (Ch) was performed with 20× MLD50 strain MB1 and mice were monitored during 14 days after challenge. Survival of mice (<i>n</i> = 8) is shown in panels a, the mean percentage of body weight (bars indicate SEM) is demonstrated in panels b. Mice were sacrificed after having dropped more than 25% of their original body weight. Panels c schematically depict the days of <i>in vivo</i> depletion of CD4-positive, CD8-positive or both CD4- and CD8-positive T-cell subset as described in <i>Material and Methods</i>. Fo...
Wild-type C57BL/6 or I-A-/-I-Enull mice were i.v. injected with 200cfu TAS2010. A) Infection-induced...
<p>Each mouse received 5×10<sup>6</sup> cells and was then challenged immediately with a lethal dose...
<p><b>a</b>) WT B6 mice were vaccinated with Ad-YF C,M,E or Ad-YF NS3 and intracranial challenged wi...
<p>Survival rates (A, C, E) and mean body weight changes (B, D, F) of C57BL/6 mice i.m. immunized on...
<p>Mice (n = 8-10/group) were immunized once with TVV+MM or PBS as negative control 4 weeks before c...
<p><b>(A)</b> Body weight changes. <b>(B)</b> Lung viral titers at day 6 post infection are presente...
SW female mice were immunized and challenged as described in Fig 2. Vaccinated mice were treated wit...
<p>Mice were immunized as described in <a href="http://www.plosntds.org/article/info:doi/10.1371/jou...
<p>Recipient mice received serum (A and B) CD4+T cells (C and D) or CD8+T cells (E and F) obtained f...
<p>Each group of mice was immunized i.m. two times on days 0 and 28 with MVAtor-tri-HA or MVAtor-mon...
<p>(A and B) AG129 mice were immunized with 1×10<sup>6</sup> DENV2 E85-VRP i.p. 14 and 5 days prior ...
<p>(A) C57BL/6 mice (wt), (B) mice depleted of CD4+ and CD8+ T cells, (C) depleted of CD8+ T cells, ...
<p>Survival rates (A, C) and body weight changes (B, D) of BALB/c mice after i.n. challenge with 20×...
<p>WT B6 mice, H-2K<sup>b</sup> KO mice, β2m KO mice, IFN-γ/Prf double KO mice and MHC class II KO m...
<p>Groups of mice (n = 5) were intragastrically immunized three times at day 0, 14, and 28 with PBS ...
Wild-type C57BL/6 or I-A-/-I-Enull mice were i.v. injected with 200cfu TAS2010. A) Infection-induced...
<p>Each mouse received 5×10<sup>6</sup> cells and was then challenged immediately with a lethal dose...
<p><b>a</b>) WT B6 mice were vaccinated with Ad-YF C,M,E or Ad-YF NS3 and intracranial challenged wi...
<p>Survival rates (A, C, E) and mean body weight changes (B, D, F) of C57BL/6 mice i.m. immunized on...
<p>Mice (n = 8-10/group) were immunized once with TVV+MM or PBS as negative control 4 weeks before c...
<p><b>(A)</b> Body weight changes. <b>(B)</b> Lung viral titers at day 6 post infection are presente...
SW female mice were immunized and challenged as described in Fig 2. Vaccinated mice were treated wit...
<p>Mice were immunized as described in <a href="http://www.plosntds.org/article/info:doi/10.1371/jou...
<p>Recipient mice received serum (A and B) CD4+T cells (C and D) or CD8+T cells (E and F) obtained f...
<p>Each group of mice was immunized i.m. two times on days 0 and 28 with MVAtor-tri-HA or MVAtor-mon...
<p>(A and B) AG129 mice were immunized with 1×10<sup>6</sup> DENV2 E85-VRP i.p. 14 and 5 days prior ...
<p>(A) C57BL/6 mice (wt), (B) mice depleted of CD4+ and CD8+ T cells, (C) depleted of CD8+ T cells, ...
<p>Survival rates (A, C) and body weight changes (B, D) of BALB/c mice after i.n. challenge with 20×...
<p>WT B6 mice, H-2K<sup>b</sup> KO mice, β2m KO mice, IFN-γ/Prf double KO mice and MHC class II KO m...
<p>Groups of mice (n = 5) were intragastrically immunized three times at day 0, 14, and 28 with PBS ...
Wild-type C57BL/6 or I-A-/-I-Enull mice were i.v. injected with 200cfu TAS2010. A) Infection-induced...
<p>Each mouse received 5×10<sup>6</sup> cells and was then challenged immediately with a lethal dose...
<p><b>a</b>) WT B6 mice were vaccinated with Ad-YF C,M,E or Ad-YF NS3 and intracranial challenged wi...